At Cellebration, we have mastered the technology for isolating the maximum number of viable stem cells from either an autologous source from the patient’s body or an allogeneic source from a matched donor to treat patients with Retinal Diseases.
Stem cell treatment for Retinal Diseases involves administration of concentrated cells in the targeted area to form colonies, adapt the properties of resident stem cells, and initiate some of the lost functions that have been compromised by the disease or injury.
These cells are administered through one of two methods after a considerable analysis of the patient’s unique history.
Local Administration
In this mode, cells are infused directly at the targeted site of injury, which in case of Retinal Diseases, stem cells are infused directly into the site.
Intravenous Administration
In this mode, cells are infused through the veins to expand blood volumes in the system, to ensure that the maximum number of cells reach the targeted area.
Once infused back into the body, these cells can be repopulated at the damaged parts of the organ. Through their strong paracrine effects, they differentiate into lost or damaged cells. With our standardized, broad based and holistic approach, it is now possible to obtain noticeable improvements in patients with Retinal Diseases for symptoms as well as their functional abilities.